Q2 EPS Estimates for Henry Schein Lowered by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Zacks Research dropped their Q2 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued on Monday, May 26th. Zacks Research analyst R. Department now expects that the company will post earnings of $1.16 per share for the quarter, down from their prior estimate of $1.19. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2025 earnings at $1.24 EPS, FY2025 earnings at $4.82 EPS, Q1 2026 earnings at $1.23 EPS, Q2 2026 earnings at $1.27 EPS, FY2026 earnings at $5.23 EPS and Q1 2027 earnings at $1.32 EPS.

Several other equities analysts have also recently commented on the company. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Piper Sandler reduced their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Wall Street Zen cut Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Barrington Research cut their price objective on Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a report on Tuesday, May 6th. Finally, Wells Fargo & Company cut their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $79.30.

Henry Schein Price Performance

Henry Schein stock opened at $71.98 on Wednesday. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49. The business has a 50-day simple moving average of $67.64 and a 200 day simple moving average of $71.61. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the business earned $1.10 earnings per share. The firm’s revenue was down .1% on a year-over-year basis.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Smartleaf Asset Management LLC raised its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares during the last quarter. Guggenheim Capital LLC grew its holdings in shares of Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after acquiring an additional 159 shares during the period. CIBC Asset Management Inc grew its holdings in shares of Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after acquiring an additional 169 shares during the period. Metis Global Partners LLC grew its holdings in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after acquiring an additional 187 shares during the period. Finally, UMB Bank n.a. grew its holdings in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after acquiring an additional 201 shares during the period. Institutional investors own 96.62% of the company’s stock.

Insider Activity

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05% decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.